Stay updated on ACP-196/Pembrolizumab in Urothelial Bladder Cancer Clinical Trial

Sign up to get notified when there's something new on the ACP-196/Pembrolizumab in Urothelial Bladder Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ACP-196/Pembrolizumab in Urothelial Bladder Cancer Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    Revision: v3.5.0 added; Revision: v3.4.3 removed.
    Difference
    0.1%
    Check dated 2026-03-19T06:08:37.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-12T02:37:57.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    No additions or deletions were detected between the old and new screenshots; the page content appears unchanged.
    Difference
    0.1%
    Check dated 2026-02-25T20:16:13.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    A new revision label 'Revision: v3.4.2' is shown and the older operating-status notice (v3.4.1) has been removed; these are maintenance updates and do not modify the study details.
    Difference
    0.5%
    Check dated 2026-02-11T11:43:03.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    The update adds a government funding notice at the top and updates the page revision from v3.4.0 to v3.4.1, neither of which changes the study data or eligibility criteria. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-04T10:22:58.000Z thumbnail image
  8. Check
    68 days ago
    Change Detected
    Summary
    Added a 'Show glossary' option and updated metadata labels, including capitalization changes to 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', and introduced a new 'Revision: v3.4.0' entry.
    Difference
    0.2%
    Check dated 2026-01-28T06:22:45.000Z thumbnail image

Stay in the know with updates to ACP-196/Pembrolizumab in Urothelial Bladder Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ACP-196/Pembrolizumab in Urothelial Bladder Cancer Clinical Trial page.